Search results

20 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Working wonders
UNC Lineberger member Frances Collichio, MD, was an investigator for a clinical trial for a treatment that uses a modified virus against melanoma. The treatment meant remission for Willis Davis, who had been diagnosed with stage IIIc melanoma in 2009.
Located in News
Located in Newsroom / UNC Lineberger in the News
UNC Lineberger researchers help map genetic mutations in skin cancer
UNC Lineberger researchers significantly contributed to a better understanding of the genetic alterations found in cutaneous melanoma as part of a multi-institution, international effort of The Cancer Genome Atlas (TCGA). Researchers collected samples from 331 patients and used several molecular methodologies to complete the study, the largest of its kind to-date for cutaneous melanoma. The findings were published in the journal Cell.
Located in News
Located in Newsroom / UNC Lineberger in the News
UNC Lineberger study finds new potential melanoma drug target
A new treatment for melanoma could be on the horizon, thanks to a finding by a UNC Lineberger Comprehensive Cancer Center-led team. In the study, which was published online today in the journal Clinical Cancer Research, the authors report that they found high levels of an enzyme in melanoma samples that they believe is a potential drug target.
Located in News
Lower survival rates connected with high-risk melanoma with mutations, study finds
A UNC Lineberger-led study found that people with higher-risk melanoma containing either BRAF or NRAS gene mutations had lower survival rates.
Located in News
UNC’s multidisciplinary melanoma conference draws health professionals from around NC
The ninth annual UNC Multidisciplinary Melanoma Conference brought more than 120 health care professionals from across the state on Thursday, February 12 to learn about the detection and treatment of melanoma.
Located in News
UNC scientists discover hidden subpopulation of melanoma cells
The research, led by Andrew C. Dudley, has implications for developing cancer drugs that target blood vessels that feed tumors.
Located in News
Karyn Stitzenberg
MD, MPH, FACS, Assistant Professor, Surgical Oncology, UNC-Chapel Hill, Cancer Prevention and Control, Gastrointestinal Oncology Program, Melanoma Program
Located in People
Michael Meyers
MD, School of Medicine, UNC-Chapel Hill, Clinical Research, UNC Breast Center, Gastrointestinal Oncology Program, Melanoma Program
Located in People